Return to Trial Database

HCRN-HN23-623

A Phase II, Single Arm, Open Label, Multi-center Trial of Neoadjuvant Radiation and Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Previously Untreated Locally Advanced, Resectable, HPV Mediated Oropharynx Cancer

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-HN23-623 being conducted in.

Knight Cancer Institute at Oregon Health & Science University

Moores Cancer Center at UC San Diego Health

Providence Cancer Institute